Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Development of an aquatic pathogen database (AquaPathogen X) and its utilization in tracking emerging fish virus pathogens in North America.

Emmenegger EJ, Kentop E, Thompson TM, Pittam S, Ryan A, Keon D, Carlino JA, Ranson J, Life RB, Troyer RM, Garver KA, Kurath G.

J Fish Dis. 2011 Aug;34(8):579-87. doi: 10.1111/j.1365-2761.2011.01270.x.

PMID:
21762169
2.

Careers-perspective interview.

Carlino J.

Trends Cell Biol. 2000 Apr;10(4):167. No abstract available.

PMID:
10740272
3.

TGF-beta 2 reduces demyelination, virus antigen expression, and macrophage recruitment in a viral model of multiple sclerosis.

Drescher KM, Murray PD, Lin X, Carlino JA, Rodriguez M.

J Immunol. 2000 Mar 15;164(6):3207-13.

4.

Transforming growth factor-beta2 regulates C3 secretion in monocytes through a protein kinase C-dependent pathway.

Drouin SM, Kiley SC, Carlino JA, Barnum SR.

Mol Immunol. 1998 Jan;35(1):1-11.

PMID:
9683259
5.

Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS.

Calabresi PA, Fields NS, Maloni HW, Hanham A, Carlino J, Moore J, Levin MC, Dhib-Jalbut S, Tranquill LR, Austin H, McFarland HF, Racke MK.

Neurology. 1998 Jul;51(1):289-92.

PMID:
9674825
6.
7.

Transforming growth factor-beta2-mediated regulation of C3 gene expression in monocytes.

Drouin SM, Carlino JA, Barnum SR.

Mol Immunol. 1996 Sep;33(13):1025-34.

PMID:
9010241
9.

Regulatory activity of endogenous and exogenous transforming growth factor beta in experimental intestinal immunopathology.

Mowat AM, Garside P, Fitton LA, Higley HR, Carlino JA.

Growth Factors. 1996;13(1-2):75-85.

PMID:
8962722
10.
11.

TGF-beta 2 decreases migration of lymphocytes in vitro and homing of cells into the central nervous system in vivo.

Fabry Z, Topham DJ, Fee D, Herlein J, Carlino JA, Hart MN, Sriram S.

J Immunol. 1995 Jul 1;155(1):325-32.

PMID:
7602108
12.

Recombinant transforming growth factor beta 1 and beta 2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin.

Grzegorzewski K, Ruscetti FW, Usui N, Damia G, Longo DL, Carlino JA, Keller JR, Wiltrout RH.

J Exp Med. 1994 Sep 1;180(3):1047-57.

13.

Studies on the mechanisms by which transforming growth factor-beta (TGF-beta) protects against allergic encephalomyelitis. Antagonism between TGF-beta and tumor necrosis factor.

Santambrogio L, Hochwald GM, Saxena B, Leu CH, Martz JE, Carlino JA, Ruddle NH, Palladino MA, Gold LI, Thorbecke GJ.

J Immunol. 1993 Jul 15;151(2):1116-27.

PMID:
8335893
14.

Long-term treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 2.

Racke MK, Sriram S, Carlino J, Cannella B, Raine CS, McFarlin DE.

J Neuroimmunol. 1993 Jul;46(1-2):175-83.

PMID:
7689586
15.

Alterations in erythropoiesis in TGF-beta 1-treated mice.

Miller KL, Carlino JA, Ogawa Y, Avis PD, Carroll KG.

Exp Hematol. 1992 Sep;20(8):951-6.

PMID:
1505640
16.

Transforming growth factor beta 1 systemically modulates granuloid, erythroid, lymphoid, and thrombocytic cells in mice.

Carlino JA, Higley HR, Creson JR, Avis PD, Ogawa Y, Ellingsworth LR.

Exp Hematol. 1992 Sep;20(8):943-50.

PMID:
1505639
17.
18.

Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.

Sampson-Johannes A, Carlino JA.

J Immunol. 1988 Nov 15;141(10):3680-6.

PMID:
3053901
20.

"Defective" receptors in steroid-resistant conditions may be proteolytic artifacts.

Sherman MR, Tuazon FB, Stevens YW, Carlino JA, Niu EM.

Adv Exp Med Biol. 1986;196:23-51. Review.

PMID:
3012978
22.

Pregnancy-associated growth factor. I. A proliferative agent which expands adult and cord T4 cells in unfractionated cultures.

Morse JH, Carlino JA, Lazzarino D, Meng TC.

Clin Immunol Immunopathol. 1985 Feb;34(2):237-53.

PMID:
3871378
23.

Excision of acquired deformity from embedded phalanges. A case report.

Carlino JC.

J Am Podiatry Assoc. 1971 Aug;61(8):307-9. No abstract available.

PMID:
5097104

Supplemental Content

Loading ...
Support Center